197 related articles for article (PubMed ID: 23955630)
1. Crystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA binding.
Nam G; Shi Y; Ryu M; Wang Q; Song H; Liu J; Yan J; Qi J; Gao GF
Protein Cell; 2013 Oct; 4(10):761-70. PubMed ID: 23955630
[TBL] [Abstract][Full Text] [Related]
2. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex.
Wang Q; Song H; Cheng H; Qi J; Nam G; Tan S; Wang J; Fang M; Shi Y; Tian Z; Cao X; An Z; Yan J; Gao GF
Cell Mol Immunol; 2020 Sep; 17(9):966-975. PubMed ID: 31273318
[TBL] [Abstract][Full Text] [Related]
3. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes.
Chen Y; Gao F; Chu F; Peng H; Zong L; Liu Y; Tien P; Gao GF
J Mol Biol; 2009 Feb; 386(3):841-53. PubMed ID: 19230061
[TBL] [Abstract][Full Text] [Related]
6. Entropically driven MHC class I recognition by human inhibitory receptor leukocyte Ig-like receptor B1 (LILRB1/ILT2/CD85j).
Shiroishi M; Kuroki K; Tsumoto K; Yokota A; Sasaki T; Amano K; Shimojima T; Shirakihara Y; Rasubala L; van der Merwe PA; Kumagai I; Kohda D; Maenaka K
J Mol Biol; 2006 Jan; 355(2):237-48. PubMed ID: 16305801
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11).
Shiroishi M; Kajikawa M; Kuroki K; Ose T; Kohda D; Maenaka K
J Biol Chem; 2006 Jul; 281(28):19536-44. PubMed ID: 16675463
[TBL] [Abstract][Full Text] [Related]
8. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.
Borrego F; Kabat J; Kim DK; Lieto L; Maasho K; Peña J; Solana R; Coligan JE
Mol Immunol; 2002 Feb; 38(9):637-60. PubMed ID: 11858820
[TBL] [Abstract][Full Text] [Related]
11. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.
Shiroishi M; Kuroki K; Ose T; Rasubala L; Shiratori I; Arase H; Tsumoto K; Kumagai I; Kohda D; Maenaka K
J Biol Chem; 2006 Apr; 281(15):10439-47. PubMed ID: 16455647
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2).
Shiroishi M; Maenaka K
Protein Pept Lett; 2009; 16(4):447-9. PubMed ID: 19356145
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
Chapman TL; Heikema AP; West AP; Bjorkman PJ
Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
[TBL] [Abstract][Full Text] [Related]
14. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2.
Hu Y; Lu X; Qiu W; Liu H; Wang Q; Chen Y; Liu W; Feng F; Sun H
Curr Drug Targets; 2022; 23(15):1430-1452. PubMed ID: 36017847
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of the LILRB1 and LILRB2 coding regions in an admixed Brazilian population sample.
Oliveira MLG; Castelli EC; Veiga-Castelli LC; Pereira ALE; Marcorin L; Carratto TMT; Souza AS; Andrade HS; Simões AL; Donadi EA; Courtin D; Sabbagh A; Giuliatti S; Mendes-Junior CT
HLA; 2022 Oct; 100(4):325-348. PubMed ID: 35754199
[TBL] [Abstract][Full Text] [Related]
16. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.
McIntire RH; Sifers T; Platt JS; Ganacias KG; Langat DK; Hunt JS
Placenta; 2008 Jul; 29(7):631-8. PubMed ID: 18538388
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of MHC class I recognition by natural killer cell receptors.
Sawicki MW; Dimasi N; Natarajan K; Wang J; Margulies DH; Mariuzza RA
Immunol Rev; 2001 Jun; 181():52-65. PubMed ID: 11513152
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
[TBL] [Abstract][Full Text] [Related]
19. Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.
Kuroki K; Matsubara H; Kanda R; Miyashita N; Shiroishi M; Fukunaga Y; Kamishikiryo J; Fukunaga A; Fukuhara H; Hirose K; Hunt JS; Sugita Y; Kita S; Ose T; Maenaka K
J Immunol; 2019 Dec; 203(12):3386-3394. PubMed ID: 31694909
[TBL] [Abstract][Full Text] [Related]
20. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.
Giles J; Shaw J; Piper C; Wong-Baeza I; McHugh K; Ridley A; Li D; Lenart I; Antoniou AN; DiGleria K; Kuroki K; Maenaka K; Bowness P; Kollnberger S
J Immunol; 2012 Jun; 188(12):6184-93. PubMed ID: 22593621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
